Back to trial details

Intake questionnaire

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Applying to Cancer Care Northwest · Spokane Valley, Washington

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 99 years old?
2. Have you been diagnosed with Breast Cancer?
3. Are you able to travel to Spokane Valley for study visits?